What is the typical CO2 (carbon dioxide) level in Diabetic Ketoacidosis (DKA) and how is it managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CO2 Levels in Diabetic Ketoacidosis (DKA)

In diabetic ketoacidosis (DKA), serum bicarbonate (CO2) levels are typically below 18 mEq/L, with severe cases showing levels below 10 mEq/L. 1 The management of these low CO2 levels primarily involves insulin therapy and fluid resuscitation rather than direct bicarbonate replacement in most cases.

Typical CO2 Levels in DKA

DKA severity can be classified based on several parameters including serum bicarbonate levels:

  • Mild DKA: CO2 levels between 15-18 mEq/L (pH 7.25-7.30)
  • Moderate DKA: CO2 levels between 10-14 mEq/L (pH 7.00-7.24)
  • Severe DKA: CO2 levels below 10 mEq/L (pH <7.00) 1

It's important to note that some patients may present with mixed acid-base disorders that can affect the typical CO2 pattern. Recent research shows that about 23.3% of DKA cases may present as "diabetic ketoalkalosis" with pH >7.4 despite having increased anion gap and ketosis 2.

Monitoring CO2 Levels

  • Blood should be drawn every 2-4 hours to determine serum electrolytes, including bicarbonate levels
  • Venous pH and anion gap should be followed to monitor resolution of acidosis
  • Direct measurement of β-hydroxybutyrate in blood is preferred for monitoring ketosis resolution 1

End-tidal CO2 (ETCO2) monitoring can be used as a noninvasive method to estimate PCO2 and indirectly assess bicarbonate levels, though it is currently underutilized (only used in 5-6% of metabolic emergencies) 3.

Management of Low CO2 Levels in DKA

Primary Treatment

  1. Insulin therapy - This is the cornerstone of DKA treatment and addresses the underlying cause of metabolic acidosis:

    • For moderate to severe DKA: 0.15 U/kg regular insulin bolus followed by continuous infusion at 0.1 U/kg/hour
    • For mild DKA: Subcutaneous or intramuscular regular insulin at 0.4-0.6 U/kg initially, then 0.1 U/kg/hour 1
  2. Fluid resuscitation:

    • Initial fluid resuscitation with normal saline at 4-14 ml/kg/h
    • Isotonic saline solution (1-1.5 L) during the first hour to restore circulatory volume
    • When glucose levels reach 250 mg/dl, switch to 5% dextrose with 0.45-0.75% saline solution 1

Bicarbonate Therapy

Bicarbonate therapy is generally reserved for patients with severe acidosis (pH <6.9) and should not be routinely administered in DKA patients with higher pH values. When indicated:

  • Recommended dose: 100 mmol sodium bicarbonate in 400 ml sterile water given at 200 ml/h for adults with pH <6.9 1

Bicarbonate therapy may also be considered in specific situations:

  • Severe, refractory acidosis with hemodynamic instability
  • Hyperkalemia
  • Compounding acidosis due to normal anion gap acidosis or acute kidney injury 4

Resolution Criteria

Treatment should continue until the following criteria are met:

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH ≥7.3 1

Potential Pitfalls and Caveats

  1. Overlooking mixed acid-base disorders: Recent research shows that DKA can present with various acid-base patterns, including diabetic ketoalkalosis where pH may be >7.4 despite severe ketoacidosis 2. Always check beta-hydroxybutyrate levels and anion gap, not just pH and bicarbonate.

  2. Inappropriate bicarbonate administration: Routine use of bicarbonate in DKA with pH >6.9 is not recommended and may lead to complications including cerebral edema (especially in pediatric patients), hypokalemia, and paradoxical CNS acidosis 1.

  3. Delayed recognition: Point-of-care testing for beta-hydroxybutyrate at triage can help identify DKA early, with a sensitivity of 98% at the manufacturer-suggested level of 1.5 mmol/L 5. This can be particularly useful when CO2 levels are not immediately available.

  4. Failure to address electrolyte imbalances: Potassium replacement should be initiated when serum potassium <5.5 mEq/L with adequate diuresis. Importantly, insulin therapy should be delayed if initial potassium is <3.3 mEq/L to avoid arrhythmias and other complications 1.

References

Guideline

Diabetic Ketoacidosis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Unknown Use of End-tidal CO2 in Metabolic Emergencies in Pediatric Patients.

Journal of translational internal medicine, 2019

Research

Point-of-care test identifies diabetic ketoacidosis at triage.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.